Literature DB >> 21419327

Radiological assessment of gynecologic malignancies.

Daniel J Bell1, Harpreet K Pannu.   

Abstract

Patients with gynecologic malignancies are evaluated with a combination of imaging modalities including ultrasonography (US), computed tomography (CT), and magnetic resonance (MR) imaging. US has a primary role in detecting and characterizing endometrial and adnexal pathology. CT is one of the primary modalities in staging malignancy and detecting recurrence. MR imaging is characterized by superior contrast resolution and specificity. This article reviews the role of radiologic imaging for the characterization of gynecologic masses and for staging, planning, and monitoring treatment, as well as for the assessment of tumor recurrence of the most common gynecologic malignancies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21419327     DOI: 10.1016/j.ogc.2011.02.003

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  6 in total

1.  A pelvic mass on ultrasonography and high human chorionic gonadotropin level: not always an ectopic pregnancy.

Authors:  Alexandre Rozenholc; Jasmine Abdulcadir; Marie-Françoise Pelte; Patrick Petignat
Journal:  BMJ Case Rep       Date:  2012-06-01

Review 2.  Imaging in oncology--over a century of advances.

Authors:  Bhuey Sharma; Axel Martin; Susannah Stanway; Stephen R D Johnston; Anastasia Constantinidou
Journal:  Nat Rev Clin Oncol       Date:  2012-11-13       Impact factor: 66.675

3.  Applying Precision Medicine to Ovarian Cancer: Proof-of-Principle for a "Molecular Second Look".

Authors:  Melissa Schwartz; Olga Camacho-Vanegas; Ashley M Wood; Matthew Dashkoff; Courtney Whitelock; Timothy T Harkins; Carmel J Cohen; Ann Marie Beddoe; Peter Dottino; John A Martignetti
Journal:  Int J Gynecol Cancer       Date:  2018-03       Impact factor: 3.437

Review 4.  What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?

Authors:  Ingfrid S Haldorsen; Njål Lura; Jan Blaakær; Daniela Fischerova; Henrica M J Werner
Journal:  Curr Oncol Rep       Date:  2019-07-29       Impact factor: 5.075

5.  Gynecologic tumors: how to communicate imaging results to the surgeon.

Authors:  Stefania Rizzo; Giuseppina Calareso; Federica De Maria; Vanna Zanagnolo; Roberta Lazzari; Agnese Cecconi; Massimo Bellomi
Journal:  Cancer Imaging       Date:  2013-12-30       Impact factor: 3.909

6.  Rapid development and use of patient-specific ctDNA biomarkers to avoid a "rash decision" in an ovarian cancer patient.

Authors:  Deep Pandya; Sandra Catalina Camacho; Maria M Padron; Olga Camacho-Vanegas; Jean-Noel Billaud; Ann-Marie Beddoe; Jon Irish; Lorene Yoxtheimer; Tamara Kalir; Jordan RoseFigura; Peter Dottino; John A Martignetti
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.